Edition:
United Kingdom

People: United Technologies Corp (UTX.N)

UTX.N on New York Stock Exchange

138.06USD
13 Sep 2019
Change (% chg)

$0.60 (+0.44%)
Prev Close
$137.46
Open
$138.00
Day's High
$139.37
Day's Low
$137.83
Volume
656,311
Avg. Vol
799,173
52-wk High
$144.24
52-wk Low
$100.50

Garnier, Jean-Pierre 

Dr. Jean-Pierre Garnier, Ph.D., is an Independent Director of United Technologies Corporation. He is Chairman of Actelion Ltd. (biopharmaceuticals) and an Operating Partner at Advent International (global private equity). He served as CEO of Pierre Fabre SA from 2008 to 2010, and as CEO and Executive Member of the Board of Directors of GlaxoSmithKline plc from 2000 to 2008. He served as CEO of SmithKline Beecham plc in 2000 and as Chief Operating Officer and Executive Member of the Board of Directors from 1996 to 2000. Dr. Garnier is a director of Radius Health, Inc. and Chairman of the Board of Alzheon, Inc. (non-public). He served as Chairman of NormOxys, Inc. (biopharmaceuticals) and as a director of Renault S.A. He serves on the Advisory Board of the Newman’s Own Foundation and is a former board member of the Stanford Advisory Council on Interdisciplinary Biosciences, Weill Cornell Medical College and the Dubai International Capital Advisory Board. In 2009, he was made a Knight Commander of the British Empire and in 2007 was named Officier de la Légion d’Honneur of France. Chief Executive Officer, SmithKline Beecham plc (pharmaceuticals), 2000

Basic Compensation

Total Annual Compensation, USD --
Restricted Stock Award, USD 325,000
Long-Term Incentive Plans, USD --
All Other, USD 1,236
Fiscal Year Total, USD 326,236

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Gregory Hayes

18,418,300

Akhil Johri

6,454,570

David Gitlin

6,442,190

Robert Leduc

10,305,000

Judith Marks

6,512,950

Robert McDonough

5,935,610
As Of  31 Dec 2018